Curcumin in Kidney Transplant Recipients

Running, not enrolling · Not applicable · Has a placebo group

Conditions studied: Disorder Related to Renal Transplantation

In brief

The primary goal of this study is to investigate if curcumin is beneficial for kidney transplant recipients, a population with extensive baseline vascular dysfunction and cognitive impairment who have few treatment options. The possible mechanisms by which curcumin improves vascular function will be evaluated as well as whether curcumin improves cognitive function in these patients.

Key facts

Study ID

NCT03935958

Run by

University of Illinois at Chicago

People needed

14

Starts

2019-11-01

Expected to finish

2027-05-31

Last updated by the study team

2026-07-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The subject is a recipient of a living donor or deceased donor kidney only transplant
• The subject is > 18 years of age

You may not qualify if…

• The subject has had a multi-organ transplant
• Subjects that were taking curcumin pre-transplant

Where it is running

• University of Illinois at Chicago — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.